IMUNON announces executive transition: Josh Blacher appointed interim CFO as Jeffrey Church retires
Seeking Alpha ·
IMUNON (IMNN) announced a transition in its financial leadership. Jeffrey Church has retired from his role as interim CFO, effective July 1, 2026. He is succeeded by seasoned life sciences financial executive Josh Blacher, who will serve as the
DYAX Investor Sentiment
Bullish (Long) 43% · Bearish (Short) 57%
254 participants
Related News
- Tessenderlo to buy ~20% stake in FMC Corp for $400M
- Li Auto June deliveries slip 15% Y/Y
- Australia's manufacturing PMI hits 5-month high of 51.5 in June
- SpaceX Nears a Major Milestone Within 15 Days, and Investors Should Pay Attention
- Japan Manufacturing PMI signals 6th month of growth; BOJ sentiment hits 8-year high
- Microsoft Layoffs Coming Next Week? MSFT Stock Climbs Overnight, Retail Stays Bullish